• Investors
  • News
  • Careers
  • Contact
  • Global Need
    • Vaccines
    • History & Impact
  • Our Solution
    • Oral Vaccines
    • Technology
    • Vaccine Advantages
    • Platform Advantages
  • Pipeline
    • Research & Development
    • Norovirus
    • Influenza
    • RSV
    • HPV
  • About Us
    • Our Mission
    • Our Team
    • Careers
    • Contact
    • Compliance
  • Investors
  • News
  • Careers
  • Contact

Single

1796

Edward Jenner was one of many seeking to defeat the “speckled monster” of smallpox, and it was common lore that dairymaids seemed immune to smallpox after contracting cowpox. In May 1796, using matter from fresh cowpox lesions, Jenner inoculated an 8-year-old boy. In July, he demonstrated that the boy was protected from smallpox and called this new procedure vaccination, after vaccinia, the Latin name for cowpox.Jenner’s first paper on the subject, which described the first successful control of an infectious disease by the deliberate use of vaccination, was rejected.

Reference: Riedel S. Proc (Bayl Univ Med Cent). 2005;18:21-5.

Post navigation

Previous PostPrevious
Next PostNext
Media Contacts

Katie Hogan, WCG
415.658.9745
khogan@wcgworld.com

Samir Singh, Vaxart
908.720.622,4
ssignh@vaxart.com

Get Updates

Subscribe to receive news alerts now.

© 2020 Vaxart, Inc., All rights reserved. Terms of UsePrivacy Policy